Invitrogen, Luminex Extend and Expand License | GenomeWeb
NEW YORK, (GenomeWeb News) – Invitrogen and Luminex jointly announced today that they have extended and expanded a licensing agreement for Luminex’s multiplex technology and systems.
 
The new license extends the lifetime of the license and expands Invitrogen’s rights to include Luminex’s next-generation multiplex detection platforms. The firms did not disclose the length of or terms of the agreement.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.